Symptomatic Deep Vein Thrombosis Following Elective Knee Arthroscopy Over the Age of 40
dc.authorid | Erem, Murat/0000-0002-9743-5515 | |
dc.authorid | Ozcan, Mert/0000-0002-2009-1881 | |
dc.authorwosid | Erem, Murat/P-6240-2018 | |
dc.contributor.author | Ozcan, Mert | |
dc.contributor.author | Erem, Murat | |
dc.contributor.author | Turan, Fatma Nesrin | |
dc.date.accessioned | 2024-06-12T10:52:33Z | |
dc.date.available | 2024-06-12T10:52:33Z | |
dc.date.issued | 2019 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Thromboprophylaxis following arthroscopic knee surgery (AKS) is not clear in the literature. The purpose of this study was to present the incidence of symptomatic deep vein thrombosis (DVT) following elective AKS over the age of 40. The secondary purpose was to investigate risk factors associated with venous thromboembolic events (VTEs). Surgical database and outpatient clinic follow-up charts of the patients who underwent AKS for any reason were included in the study. Odds for risk factors such as previous medical history of thrombosis, any family history for clotting disorders, diabetes mellitus (DM), oral contraceptive usage, body mass index, history of malignancy, and smoking were evaluated. The incidence of DVT following AKS significantly increased in the patients older than 40 years who had a previous medical history of VTE, DM, and smoking. A variety of guidelines exist for VTE prophylaxis; however, one should focus on risk factors related to the patient's medical history and current medical conditions. In this study, smoking, DM, and previous history of DVT increased DVT risk significantly, and thromboprophylaxis should be kept in mind for these patients. | en_US |
dc.identifier.doi | 10.1177/1076029619852167 | |
dc.identifier.issn | 1076-0296 | |
dc.identifier.issn | 1938-2723 | |
dc.identifier.pmid | 31115250 | en_US |
dc.identifier.scopus | 2-s2.0-85066481866 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1177/1076029619852167 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/18757 | |
dc.identifier.volume | 25 | en_US |
dc.identifier.wos | WOS:000468973700001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Inc | en_US |
dc.relation.ispartof | Clinical And Applied Thrombosis-Hemostasis | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Arthroscopy | en_US |
dc.subject | Deep Vein Thrombosis | en_US |
dc.subject | Knee | en_US |
dc.subject | Thromboprophylaxis | en_US |
dc.subject | Venous Thromboembolism | en_US |
dc.subject | Anterior Cruciate Ligament | en_US |
dc.subject | Molecular-Weight Heparin | en_US |
dc.subject | Venous Thromboembolism | en_US |
dc.subject | Risk-Factors | en_US |
dc.subject | Pulmonary-Embolism | en_US |
dc.subject | Surgery | en_US |
dc.subject | Thromboprophylaxis | en_US |
dc.subject | Complications | en_US |
dc.subject | Prevention | en_US |
dc.subject | Prophylaxis | en_US |
dc.title | Symptomatic Deep Vein Thrombosis Following Elective Knee Arthroscopy Over the Age of 40 | en_US |
dc.type | Article | en_US |